Today: 30 April 2026
Browse Category

NASDAQ:CLDX 26 February 2026

Celldex Therapeutics (CLDX) stock slips in premarket after 24% rally on Phase 3 barzolvolimab milestone

Celldex Therapeutics (CLDX) stock slips in premarket after 24% rally on Phase 3 barzolvolimab milestone

Celldex Therapeutics shares fell about 4% to $29.58 in premarket trading Thursday, after surging 24% the previous session. The company completed enrollment in two global Phase 3 barzolvolimab studies for chronic spontaneous urticaria six months ahead of schedule. Topline data are expected in Q4 2026, with a U.S. BLA filing planned for 2027. Celldex ended 2025 with $518.6 million in cash and posted a full-year net loss of $258.8 million.

Stock Market Today

  • Advanced Micro Devices Shares Surge on Analyst Upgrade Ahead of Q1 Earnings
    April 29, 2026, 6:56 PM EDT. Advanced Micro Devices (AMD) shares climbed 4.30% to $337.11 on April 29, driven by analyst upgrades and growing demand for data center GPUs supporting artificial intelligence (AI) workloads. The surge reflects increased spending by cloud providers and AI developers expanding data center capacity. Trading volume hit 43.2 million shares, about 13% above the average. Competitors showed mixed results: Intel rose nearly 12%, while Nvidia declined 1.79%. Investors are now focused on AMD's May 5 earnings report, expecting insights into data center revenue and future GPU growth amid competition from Nvidia and Intel. The report should clarify market positioning as AI infrastructure deployment accelerates.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
Go toTop